EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Perfluorooctane sulfonate directly interacts with IRF3 to attenuate antiviral innate immunity

Qiuju Liang iD, Yun Li, Zeqing Sun, Longge Wang, Changying Li, Peiyu Fang, Qi Zhang, Juan Li, Xiaoyi Sun, Changguo Chen iD, Chu Wang, Guijie Guo iD und 2 weitere

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2536274123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Qiuju Liang und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beiji…. Hauptthemen laut MEDLINE: Interferon Regulatory Factor-3, Immunity, Innate, Alkanesulfonic Acids, Fluorocarbons. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Strategic Priority Research Program of the Chinese Academy of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perfluorooctane sulfonate (PFOS), a prominent per- and polyfluoroalkyl substance (PFAS), has raised significant public health concerns due to its widespread use, environmental persistence, and bioaccumulation potential. Both epidemiological and experimental studies demonstrate that PFOS exposure causes immunotoxicity and disrupts both innate and adaptive immunity. However, the specific effects of PFOS on innate antiviral immunity remain poorly understood. Here, by integrating multi-omics analysis with in vitro and in vivo studies, we establish that PFOS exposure at subtoxic doses compromises antiviral defense by suppressing type I interferon production, thereby enhancing the replication of a broad range of viruses. Mechanistically, PFOS interacts with IRF3 at Val319, Asp328, and Arg341, inducing conformational changes that disrupt the TBK1–IRF3 interaction. This disruption inhibits subsequent IRF3 phosphorylation, dimerization, and nuclear translocation, which in turn suppresses type I interferon production and facilitates viral replication. Additionally, wild-type IRF3, but not a binding-deficient mutant, restores PFOS-mediated suppression of innate antiviral immunity in IRF3-deficient cells or knockout mice. Furthermore, association studies in patients with respiratory syncytial virus, influenza, or hepatitis B virus infection showed that elevated serum PFOS levels are correlated with increased viral loads, as indicated by lower Ct values or higher HBV DNA levels. Similarly, NHANES data link higher serum PFOS to lower vaccine antibody levels. Together, our results demonstrate that PFOS directly targets IRF3 to impair innate antiviral immunity, thereby enhancing host susceptibility to viral infection at environmental exposure levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Regulatory Factor-3Immunity, InnateAlkanesulfonic AcidsFluorocarbonsAnimalsMiceHumansInterferon Type IVirus ReplicationProtein Serine-Threonine KinasesPhosphorylation

Stichwörter der Autor:innen

IRF3PFOSantiviral immunitytype I interferonviral susceptibility

Substanzen

Interferon Regulatory Factor-3perfluorooctane sulfonic acidAlkanesulfonic AcidsFluorocarbonsInterferon Type IIrf3 protein, mouseProtein Serine-Threonine KinasesIRF3 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.
  • College of Resources and Environment, University of Chinese Academy of Sciences, Beijing 100085, China.
  • Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.
  • Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning 530021, China.
  • Guangxi Key Laboratory of Environment and Health Research, Guangxi Medical University, Nanning 530021, China.
  • Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China.

ORCID-Profile: Qiuju Liang, Changguo Chen, Guijie Guo, Ming Gao, Sijin Liu

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Strategic Priority Research Program of the Chinese Academy of Science

Zitieren

APA

Liang, Q., Li, Y., Sun, Z., Wang, L., Li, C., Fang, P., Zhang, Q., Li, J., Sun, X., Chen, C., Wang, C., Guo, G., Gao, M., & Liu, S. (2026). Perfluorooctane sulfonate directly interacts with IRF3 to attenuate antiviral innate immunity. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2536274123

Vancouver

Liang Q, Li Y, Sun Z, Wang L, Li C, Fang P, et al. Perfluorooctane sulfonate directly interacts with IRF3 to attenuate antiviral innate immunity. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2536274123

BibTeX
@article{Liang2026,
  author = {Liang, Qiuju and Li, Yun and Sun, Zeqing and Wang, Longge and Li, Changying and Fang, Peiyu and Zhang, Qi and Li, Juan and Sun, Xiaoyi and Chen, Changguo and Wang, Chu and Guo, Guijie and Gao, Ming and Liu, Sijin},
  title = {Perfluorooctane sulfonate directly interacts with IRF3 to attenuate antiviral innate immunity},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2536274123}
}
Kostenlos starten →